(Q80246733)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17472422%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

meta-analysis

0 references

title

An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17472422%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

Joachim Wernicke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17472422%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Alberto Lledó

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17472422%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Joel Raskin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17472422%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Daniel K Kajdasz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17472422%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Fujun Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17472422%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17472422%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17472422%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17472422%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17472422%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

437-455

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17472422%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002018-200730050-00007

30 December 2019

exact match

0 references

cites work

Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine

1 reference

12 December 2020

Considerations for the use of antidepressants in patients with cardiovascular disease

1 reference

12 December 2020

Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.

1 reference

12 December 2020

Duloxetine in the long-term treatment of major depressive disorder

1 reference

12 December 2020

The effects of supratherapeutic doses of duloxetine on blood pressure and pulse rate

1 reference

12 December 2020

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

1 reference

12 December 2020

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

1 reference

12 December 2020

Evidence of the dual mechanisms of action of venlafaxine

1 reference

12 December 2020

SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants

1 reference

12 December 2020

Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial

1 reference

12 December 2020

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

Anchoring perceptions of clinical change on accurate recollection of the past: memory enhanced retrospective evaluation of treatment (MERET).

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

1 reference

12 December 2020

Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians

1 reference

12 December 2020

Duloxetine for the treatment of major depressive disorder.

1 reference

12 December 2020

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.

1 reference

12 December 2020

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

1 reference

12 December 2020

Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?

1 reference

12 December 2020

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression

1 reference

12 December 2020

Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence

1 reference

12 December 2020

Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients

1 reference

12 December 2020

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis

1 reference

12 December 2020

Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorder.

1 reference

12 December 2020

Impact of duloxetine on quality of life for women with symptoms of urinary incontinence

1 reference

12 December 2020

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

1 reference

12 December 2020

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

1 reference

12 December 2020

Duloxetine vs. placebo in patients with painful diabetic neuropathy

1 reference

12 December 2020

Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial

1 reference

12 December 2020

Clinical characteristics of imipramine-induced orthostatic hypotension

1 reference

12 December 2020

SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability

1 reference

12 December 2020

Pharmacological treatment of women awaiting surgery for stress urinary incontinence

1 reference

12 December 2020

Orthostatic side effects of clomipramine and moclobemide during treatment for depression

1 reference

12 December 2020

Cardiovascular Effects of Tricyclic Antidepressants

1 reference

12 December 2020

The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations

1 reference

12 December 2020

Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinence

1 reference

12 December 2020

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.

1 reference

12 December 2020

Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain

1 reference

12 December 2020

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis

1 reference

12 December 2020

Cardiovascular Effects of Tricyclic and Tetracyclic Antidepressants

1 reference

12 December 2020

Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP.

1 reference

12 December 2020

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

1 reference

12 December 2020

The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction

1 reference

12 December 2020

Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes.

1 reference

12 December 2020

Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

1 reference

12 December 2020

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder

1 reference

12 December 2020

Cardiac safety of citalopram: prospective trials and retrospective analyses

1 reference

12 December 2020

Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats

1 reference

12 December 2020

Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

Fluoxetine versus other types of pharmacotherapy for depression

1 reference

12 December 2020

Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial

1 reference

12 December 2020

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

1 reference

12 December 2020

Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial

1 reference

12 December 2020

Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.

1 reference

12 December 2020

QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study.

1 reference

12 December 2020

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

1 reference

12 December 2020

A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence

1 reference

12 December 2020

The pharmacologic treatment of depression

1 reference

12 December 2020

Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review

1 reference

12 December 2020

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

1 reference

12 December 2020

Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial

1 reference

12 December 2020

A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs.

1 reference

12 December 2020

Duloxetine Versus Placebo for the Treatment of North American Women With Stress Urinary Incontinence

1 reference

12 December 2020

Duloxetine versus placebo in the treatment of stress urinary incontinence

1 reference

12 December 2020

An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.

1 reference

12 December 2020

Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants.

1 reference

12 December 2020

Dual monoamine modulation for improved treatment of major depressive disorder

1 reference

12 December 2020

Risk of syncope in the elderly and consumption of drugs: a case-control study

1 reference

12 December 2020